| 我国药品专利强制许可制度的法律规制研究 |
| |
| 引用本文： | 向智才,金晋,张朝阳.我国药品专利强制许可制度的法律规制研究[J].科技管理研究,2020,40(19):147-152. |
| |
| 作者姓名： | 向智才 金晋 张朝阳 |
| |
| 作者单位： | 中国人民公安大学,北京100038;北京知识产权法院,北京 100097 |
| |
| 基金项目： | 国家重点研发计划项目（ 2018YFC0824405） |
| |
| 摘 要： | 面对严峻的公共健康形势,药品专利强制许可制度在平衡专利私权与公众健康权之间实现着有效的动态平衡。通过梳理我国药品专利强制许可立法的演变过程,从政策定位、法理依据和社会需求三个层面对该制度存在的现实基础进行分析,指出我国药品专利强制许可制度之所以处于“零实施”的现状,既有政策负效应的障碍,也在制度模式和立法上存在缺陷。进一步明确制度的政策定位,通过立法完善制度设计,促进该制度在我国的实践落成和法律完善。
|
| 关 键 词： | 药品专利 强制许可 公共健康 TRIPS协议 |
| 收稿时间： | 2019/11/11 0:00:00 |
| 修稿时间： | 2020/1/21 0:00:00 |
On the legislation of perfecting the compulsory license system of pharmaceutical patents in China |
| |
| Abstract: | In the face of severe public health situation, the pharmaceutical patent compulsory license system achieves an effective dynamic balance between patent private right and public health right. By reviewing the evolution process of medicine patent compulsory licensing legislation in our country, from the legal basis for policy orientation, and social needs three aspects analyze the realistic foundation of the existence of the system, points out that the drug patent compulsory license system in China is in the status quo of the implementation of "zero", the negative effects of existing policy barriers, also exists in the system model and legislative defects. To further clarify the policy positioning of the system, improve the system design through legislation, and promote the completion of the system in practice and legal improvement. |
| |
| Keywords: | pharmaceutical patents compulsory licensing public health TRIPS Agreement |
| 本文献已被 万方数据 等数据库收录！ |
| 点击此处可从《科技管理研究》浏览原始摘要信息 |
| 点击此处可从《科技管理研究》下载免费的PDF全文 |
|
